FDA issued a Warning Letter to Aurobindo Pharma Limited on 6/20/2019 as a result of this inspection.
FDA investigators audited the Aurobindo Pharma Limited (Unit XI) - Pydibhimavaram, India facility and issued inspectional observations (via FDA 483) on 09 Feb 2019.
Add To Cart
- Category: Human Drugs
- Inspection end: 09 Feb 2019
- Location: Pydibhimavaram, India
- FEI: 3004611182